Prospective longitudinal multicentre observational study carried out on a population of patients undergoing minimally invasive spine surgery and divided into two parallel cohorts according to the presence or absence of a Enhanced Recovery After Surgery (ERAS) programme. The patient will be assessed during 4 visits: At inclusion before surgery, at D0 (day of surgery), at D1 (postoperative visit) and at M1 (follow-up visit).
On a population of patients undergoing minimally invasive lumbar spine surgery divided into two cohorts of equal size according to the presence or absence of a Enhanced Recovery After Surgery (ERAS) programme: Primary objective To compare the percentage of therapeutic success achieved in each group one month after surgery. Secondary objectives: to compare between groups: * Postoperative pain intensity at D1 and M1 * Analgesic consumption (in stages) at D1 and M1 * Pain-free walking distance at M1 * Surgery conditions (duration of operation, duration of hospitalisation) * Frequency of adverse events related to surgery (infection rate, 1 month recovery rate, transfusion requirements) * Emotional impact of the management
Study Type
OBSERVATIONAL
Enrollment
100
Minimally invasive surgery of the lumbar spine with Enhanced Recovery After Surgery (ERAS)
Classic Minimally invasive surgery of the lumbar spine
Clinique Geoffroy Saint-Hilaire
Paris, France
Oswestry Disability Index improvement
The Oswestry Disability Index (Appendix 1) (also known as the Oswestry Low Back Pain Disability) is the gold standard tool for assessing functional disability related to low back pain and functional recovery after surgery. It consists of ten questions rated from 0 to 5 (from most to least favourable). The result is expressed as a percentage according to the following formula \[score obtained / (maximum score)\] X 100. The maximum score is 50 if all the questions have been filled in, 45 if one question has not been filled in etc..... The disability rate, corresponding to the percentage, obtained is considered minimal between 0 and 20%, moderate between 21 and 40% and severe above 41%. Therapeutic success defined as an improvement ≥30% in the Oswestry Disability Index between initial and final visit is the primary endpoint
Time frame: Month 1
Post-operative pain
The intensity of the pain will be assessed using a simple numerical scale (ENS) graduated from 0 (no pain) to 10 (worst pain imaginable).
Time frame: Day 1
Post-operative pain
The intensity of the pain will be assessed using a simple numerical scale (ENS) graduated from 0 (no pain) to 10 (worst pain imaginable).
Time frame: Month 1
Consumption of level I, II and II analgesics
Consumption of level I, II and II analgesics. Count of treatments
Time frame: Day 1
Consumption of level I, II and II analgesics
Consumption of level I, II and II analgesics
Time frame: Month 1
Pain-free walking perimeter
Measurement in meters of the distance the patient travels until he/she is forced to stop due to pain
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Month 1
Evolution of Hospital Anxiety and Depression (HAD) scale score and sub-scores
The emotional impact of the disease will be more precisely evaluated by the Hospital Anxiety and Depression (HAD) questionnaire, a screening tool for the most common manifestations of anxiety and depressive disorders to be completed by the patient. The scale comprises 14 questions, with 7 items assessing anxiety and 7 items assessing depression. A minimum score of 10 on one of the sub-scores was retained as a criterion for detecting depressive or anxious manifestations. The HAD questionnaire will be completed by the patient at the inclusion visit (V1) and at the end of the study (V4).
Time frame: Month 1
Duration of intervention
Duration of the surgery in hours
Time frame: Day 1
Length of hospital stay
Length of hospital stay in days
Time frame: Month 1
Adverse events related to surgery
All adverse events related to surgery will be collected and compared in the 2 groups
Time frame: Month 1
Visual Analogue Scale overall patient satisfaction
The patient's satisfaction with his or her treatment and results will be assessed at the end of the study on a visual analogue scale graduated from 0 (very dissatisfied) to 10 (very satisfied).
Time frame: Month 1